Edge Therapeutics, Inc. 4
4 · Edge Therapeutics, Inc. · Filed Feb 18, 2016
Insider Transaction Report
Form 4
Macdonald R. Loch
DirectorChief Scientific Officer
Transactions
- Award
Stock Option (Right to Purchase)
2016-02-16+85,000→ 85,000 totalExercise: $6.99Exp: 2026-02-16→ Common Stock (85,000 underlying)
Footnotes (1)
- [F1]This option, representing a right to purchase a total of 85,000 shares of Common Stock, will become exercisable on February 16, 2017, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.